Identification of an isoquinoline-derived quinazoline hybrid as a transcriptional inhibitor of fatty acid synthase to suppress hepatitis C virus production
Biochemical and Biophysical Research Communications · 2026-09 · 829 · 154182
DOI: 10.1016/j.bbrc.2026.154182 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2026-09. Verfasst von Xiaowei Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Hamamatsu University School of Medicine, Shizuoka, Japan. Hauptthemen laut MEDLINE: Hepacivirus, Antiviral Agents, Quinazolines, Virus Replication. Die Arbeit nennt 29 Literaturangaben. Gefördert von: Government of Japan Ministry of Education Culture Sports Science and Technology, AMED.
Abstract (Originalsprache)
Host-directed antiviral strategies provide an alternative approach to overcome the rapid emergence of drug-resistant viruses. Fatty acid synthase (FASN), a key enzyme in de novo lipogenesis, is exploited by multiple viruses to support their life cycles. To date, FASN-targeted therapies have focused on enzyme activity inhibition. However, since catalytic inhibition of FASN carries the risk of disrupting lipid homeostasis in normal tissues, FASN expression suppression was considered a potentially effective alternative. To identify inhibitors of FASN expression, we established a CRISPR-engineered HuH-7 reporter cell line in which a HiBiT tag was knocked into the endogenous FASN locus, enabling quantitative monitoring of native FASN protein levels. The high-throughput screening of 19,912 small molecules resulted in the identification of a potent suppressor of FASN production: an isoquinoline-derived quinazoline hybrid designated IQZ-1. Promoter analyses revealed that IQZ-1 inhibits FASN transcription at least via the proximal sterol regulatory elements of the FASN promoter. Using hepatitis C virus (HCV) as a lipid-dependent model virus, we demonstrated that IQZ-1 significantly reduced intracellular viral RNA levels and markedly suppressed infectious particle production. Subgenomic replicon analyses indicated partial inhibition of viral genome replication, while immunofluorescence studies revealed reduced abundance of lipid droplets, essential platforms for HCV virion formation, in infected cells. These findings suggest that transcriptional suppression of FASN impairs both membrane-associated replication complex formation and virion assembly. Collectively, our results establish proof of concept that targeting FASN synthesis, rather than enzymatic activity, effectively disrupts lipid-dependent viral propagation and represents a promising host-directed antiviral strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, Hamamatsu University School of Medicine, Shizuoka, Japan.
- Department of Microbiology and Immunology, Hamamatsu University School of Medicine, Shizuoka, Japan; Department of Infectious Disease Research, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Japan. Ele…
- Institute of Transformative Bio-Molecules (WPI-ITbM), Nagoya University, Nagoya, Aichi, Japan; Center for One Medicine Innovative Translational Research (COMIT), Nagoya University, Nagoya, Aichi, Japan.
- Institute of Transformative Bio-Molecules (WPI-ITbM), Nagoya University, Nagoya, Aichi, Japan.
- Department of Microbiology and Immunology, Hamamatsu University School of Medicine, Shizuoka, Japan; Next Generation Creative Education Center for Medicine, Engineering, and Informatics, Hamamatsu University School of M…
Förderung
- Government of Japan Ministry of Education Culture Sports Science and Technology
- AMED
Zitieren
APA
Wang, X., Satoh, S., Jiao, M., Konno, A., Ito, M., Sato, A., Kadofusa, N., Iwatani, Y., & Suzuki, T. (2026). Identification of an isoquinoline-derived quinazoline hybrid as a transcriptional inhibitor of fatty acid synthase to suppress hepatitis C virus production. Biochemical and Biophysical Research Communications, 829, 154182. https://doi.org/10.1016/j.bbrc.2026.154182
Vancouver
Wang X, Satoh S, Jiao M, Konno A, Ito M, Sato A, et al. Identification of an isoquinoline-derived quinazoline hybrid as a transcriptional inhibitor of fatty acid synthase to suppress hepatitis C virus production. Biochemical and Biophysical Research Communications. 2026;829:154182. doi:10.1016/j.bbrc.2026.154182
BibTeX
@article{Wang2026,
author = {Wang, Xiaowei and Satoh, Shinya and Jiao, Mengyu and Konno, Alu and Ito, Masahiko and Sato, Ayato and Kadofusa, Naoya and Iwatani, Yasumasa and Suzuki, Tetsuro},
title = {Identification of an isoquinoline-derived quinazoline hybrid as a transcriptional inhibitor of fatty acid synthase to suppress hepatitis C virus production},
journal = {Biochemical and Biophysical Research Communications},
year = {2026},
volume = {829},
pages = {154182},
doi = {10.1016/j.bbrc.2026.154182}
}
EUVIMED